Report on clinical use of BRL 1241 in children with staphylococcal and streptococcal infections.

British medical journal ·Vol. 2 ·No. 5200 ·1960-09-03 ·Pages 703-6

STEWART GT, NIXON HH, COLES HM, KESSON CW, LAWSON D, THOMAS RG, MISHRA JN, MITCHELL ME, SEMMENS JM, WADE TH

Abstract

暂无摘要

Keywords

PENICILLIN/therapy STREPTOCOCCAL INFECTIONS/therapy

MeSH Terms

Penicillins/therapy Staphylococcus Streptococcal Infections/therapy

Chemicals

Penicillins

Authors & Affiliations

10 authors, click to expand affiliations / ORCID

STEWART G T

NIXON H H

COLES H M

KESSON C W

LAWSON D

THOMAS R G

MISHRA J N

MITCHELL M E

SEMMENS J M

WADE T H

References (6)

6 references, click to expand

A new penicillin (BRL 1241) active against penicillin-resistant staphylococci.
Br Med J. 1960 Sep 3;2(5200):690-3 PMID: 14410240
Absorption and excretion of a new antibiotic (BRL 1241).
Br Med J. 1960 Sep 3;2(5200):700-3 PMID: 14410248
Synthesis of penicillin: 6-aminopenicillanic acid in penicillin fermentations.
Nature. 1959 Jan 24;183(4656):257-8 PMID: 13622762
Sensitivity of staphylococcus pyogenes to benzylpenicillin and BRL 1241.
Br Med J. 1960 Sep 3;2(5200):708-9 PMID: 13838106
A New Synthetic Penicillin.
Br Med J. 1960 Sep 3;2(5200):687-90 PMID: 20788939
Microbiological studies on sodium 6-(2, 6 dimethoxybenzamido) penicillanate monohydrate (BRL 1241) in vitro and in patients.
Br Med J. 1960 Sep 3;2(5200):694-9 PMID: 13834591

Article Info

Journal

British medical journal

Abbr.

Br Med J

ISSN

0007-1447

DOI

10.1136/bmj.2.5200.703

Published

1960-09-03

Pages

703-6

Language

English

Region

England

NLM ID

0372673

PMCID

PMC2097988

Subset

External Links

PubMed source DOI: 10.1136/bmj.2.5200.703 PMC Full Text

Analysis Services

Report on clinical use of BRL 1241 in children with staphylococcal and streptococcal infections.

Contact

WeChat Official Account